how bpc 157 works BPC-157 Oral vs Injection: Benefits, Bioavailability & Recovery Peptide Therapy for Inflammation: A

Nie oznacza to jednak, e zawsze trzeba czy oba peptydy

[DOI] [PMC free article] [PubMed] [Google Scholar] 12.Polkowska-Pruszyska B., Gerkowicz A., Szczepanik-Kuak P., Krasowska D

A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007

The absence of approval means there is no licensed manufacturer, no quality standards enforced by health authorities, and no legal framework for medical use